Loading...
2cureX
powered by Stokk.io

Q2 Investor update

Wed, 12 Jul, 2023, 20:00 – 20:30
This event has ended. Sign up below to watch the recording.
Sign in to access all the features of the platform.

How does this Q&A work:

This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.

The company will address as many questions as possible, and focus on those questions most wanted by investors.

Speakers at this event:

Fernando Andreu
CEO
Ole Thastrup
CSO & Founder
Kenneth G. Johansen
CFO

17 Questions

A
Anders Brändström
July 12, 2023
Asked Live

Thanks for these investor updates. They are much appreciated.

K
K**** *****
July 12, 2023
Asked Live

I think you had some great progress the past years, great work. Just a bit more personal question. How do the negative share and some dissatisfied shareholders affect your "commitment" and energy at 2cureX? Thanks again for your fantastic work!

V
V**** *****
July 5, 2023

If we look at other industries that are not comparable, many companies begin to close markets and focus on specific geographic areas as operating in multiple markets and multiple countries is more expensive. Is this a risk or issue for 2CureX as well, as you are expecting to cover 25 countries end of this year which seems like many different countries compared to the amount of revenue and tests you expect or is it important to covermany countries that early?

S
S**** *****
July 5, 2023

Have you experienced increased interest from existing and potentially enrolled IndiTreat hospitals after the positive trial results was published in Journal of Experimental & Clinical Cancer Research?

A
Anders Leufven
July 11, 2023

Tests through Ignite:
How many tests done Q2?
How many payed full price?
How many tests through other ways than Inditreat during Q2?
Forecast for Q3,Q4 and 2024, 2025?
How many full price tests is forecasted for the mentioned periods?

How many tests do u expect to need to been uptaken in guidelines? When can this occur?

H
H**** *****
July 10, 2023

From 2022 to now, the share has fallen by approx. 80%.

What reasons do we investors still have to believe in 2curex and keep investing and have any idea who it is that is selling? (Large / Small investors)

K
K**** *****
July 12, 2023

Are your sales targets for 2023 intact despite the weak start to the year?

M
M**** *****
July 12, 2023

Can you tell us more about the Inditreat test lab box? Has it been decided with a specific hospital that will start testing it now in q3/q4? Still waiting for updates to the box before starting the test?

J
J**** *****
July 12, 2023

Do you understand why the stock has collapsed completely? It would be nice to hear if your are connected or disconnected to the market and your shareholders or not? So a few of your own words and thoughts on why it has gone this bad would be very interesting. Thanks

S
S**** *****
July 12, 2023

Can you give an update on how you are working on ensuring further cash flow runway beyond 2023? Partnerships, M&A (selling to larger player), emissions? Any progress in your plans in this area?

A
A**** *****
July 11, 2023

Could you dive deeper in the plan to reach positive cash flow? It seems to me that equity/funds will come to an end with 12-18 months. What is the plan? Sell rights? New owner? New shares? Loans? I think this is the main reason why the stock share has been fallen during the last year. To me, except for increasing sales, the most important issue right now is how to fund the company further on and give the stock market (owners) a clear road forward.

H
H**** *****
July 10, 2023

Other companies have started selling their products to private individuals.
Have 2cureX thought about the same thing?
(The patients certainly have a great need)

T
T**** *****
July 10, 2023

Are you planning to start selling something anytime soon?

A
A**** *****
July 11, 2023

How many tests have been executed until end of june? Is it inline with the communicated sales plan of approx. 100 tests ? If not, what is the reason(s) for the deviation?

J
J**** *****
July 12, 2023

For years I have been asking how you will solve your financials until BE but until now no clear answer. Last time you had a funding I was told this would last until BE but this never happened. Obviously I will not be a part of another right issue but are happy that Ole has told us that we should NOT expect to be much diluted. But info on your work related to bigger investors and how you will manage to found the company until BE at these low levels and today’s climate would be appreciated? Regards

J
J**** *****
July 12, 2023

How can we see results on the work you have been doing to raise awareness and interest around your share? To me the interest looks a bit weak.

S
S**** *****
July 12, 2023

Did you manage to hire the new lab technician you were looking for on LinkedIn? Is this hiring a precaution for forecasted potential volumes later, or are you already "feeling the heat" in the lab in terms of capacity and need to expand ASAP?